By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.

OK

EQT’s Raised Offer for Karo Still Facing Some Resistance

On January 2, EQT increased its offer for Karo Pharma from SEK 36.90 per share to SEK 38.00. EQT succeeded in garnering 29.1% of the shares via acceptances of the original offer, and had purchased 19.3% outside of the offer, taking its potentialfeatured

EQT Likely Will Need to Sweeten Bid for Karo Pharma

Private equity firm EQT likely will need to raise its offer to get individual dissenting shareholders of Karo Pharma onboard, a source close to the shareholder group told CTFN.featured

Increased Ramsay Offer for Capio Well Received though Risk Seen in Minimum Condition

A large Capio shareholder indicated to CTFN that the raised offer for the company from Ramsay is worth considering, though the shareholder expressed concern about the 90% minimum condition.featured

Increase Appears Needed from Ramsay to Sway Capio Holders

Capio shareholders have received no new information from Ramsay Health Care on the Australian firm’s offer for the Gothenburg-based healthcare company, two leading Capio shareholders told CTFN.featured

Large Capio Shareholder Seeking SEK59 Plus

One of the main long-standing Swedish shareholders of Capio AB said its price expectation is higher than SEK59 for a takeover by Ramsay. The shareholder would not comment onfeatured

Kinnevik Mulling Options to Gain Antitrust Approval for Com Hem-Tele2 Merger

Swedish investment company Kinnevik, the largest shareholder in both telecoms operator Tele2 and triple-play services provider Com Hem, is reviewing a number offeatured

Swedish Shareholder Association to Pursue Claim Against Haldex

The Swedish Shareholders’ Association (Aktiespararna), which represents Haldex’s retail shareholders, is still determined to file a suit against the company and the decision takenfeatured

Swedish Shareholders Association to Sue Haldex over EGM Decision

The Swedish Shareholders’ Association (Aktiespararna), which represents Haldex’s retail shareholders, is preparing a claim to oppose the outcome of the recent vote at the extraordinary shareholders’ meeting, To Keep Reading, Request a Trial Already a subscriber? Log-infeatured

Sources Skeptical of Haldex/Knorr-Bremse Deal Outcome

With additional reporting by Rachel Rigby – Knorr-Bremse’s ongoing takeover of Swedish peer Haldex raises significant issues that may not be possible to overcome, two of the target’s former senior executivesfeatured

X

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.